BUY Monash IVF (MVF)
*** GENERAL AVICE ONLY***
Trade Date: 30/07/2024
Monash IVF Group Limited (MVF) is in the field of human fertility services and is a provider of Assisted Reproductive Services (ARS) which is the most significant component of fertility care in Australia and Malaysia.
Recommendation
Buy Monash IVF (MVF)
Entry price: Buy up to $1.36
Target Price: $1.55
Stop Loss: $1.20
Rationale:
Monash has been mainly a range bound for 12 months ranging between $1.20 to $1.50. MVF has recently pulled back and traded near the bottom end of the range. MVF has bounced nicely off this level and looks to be heading back to the high end of the range. Earnings for MVF is on August 20th 2024 so looking to get set before the news
Analysts reflects on the total IVF cycles which increased by 9.4% year-over-year in June 2024, with fresh cycles up 7.4% and frozen cycles up 12.3%.
The recent addition of carrier screening to the Medicare Benefits Schedule in November 2023, with about 60,000 tests to date, is expected to drive significant incremental IVF volume for Monash IVF.
Market share gains are anticipated by the broker supported by specialist recruitment and the acquisition of Fertility North, which is expected to add eight new specialists.
Disclaimer: The recommendation given is general advice only. It does not take into account your personal objectives, financial situation, or specific needs. This information should not be your sole resource when making such decisions. We strongly recommend you to seek the advice of financial, taxation, and legal professionals before finalising any investment decisions.